Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Gomez-Arteaga A, Orfali N, Pasciolla M, Baptiste A, Guindine I, Hsu JM, et al. Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD). Bone Marrow Transplant. 2023;58(7):835-838.

Guahmich NL, Man L, Wang J, Arazi L, Kallinos E, Topper-Kroog A, et al. Human theca arises from ovarian stroma and is comprised of three discrete subtypes. Commun Biol. 2023;6(1):7.

Dameri M, Cirmena G, Ravera F, Ferrando L, Cuccarolo P, Stabile M, et al. Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: A critical review of the literature for the RENOVATE study protocol. Crit Rev Oncol Hematol. 2023;185:103963.

Miller RC, Magro CM, Melnick LE, Lipner SR. Acral Fibrochondromyxoid Tumor Presenting as Enlarging Nodule Involving the Distal Fingertip and Hyponychium: A Case Report. Case Rep Dermatol. 2023;15(1):56-61.

Saoud C, Lam H, Ali SZ. Fine-Needle Aspiration of Sarcomas Metastatic to Lymph Nodes: A Cytomorphologic Study over a 10-Year Period. Acta Cytol. 2023;67(5):493-506.

Itkin T, Houghton S, Schreiner R, Lin Y, Badwe CR, Voisin V, et al. Transcriptional Activation of Regenerative Hematopoiesis via Vascular Niche Sensing. bioRxiv. 2023.

Magahis PT, Westerveld D, Simons M, Hissong E, Carr-Locke DL, Sampath K, et al. EUS-guided liver biopsy using a novel hydrostatic stylet technique. VideoGIE. 2023;8(3):104-106.

Sloan SL, Brown F, Long M, Weigel C, Koirala S, Chung J-, et al. PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma. Blood. 2023;142(10):887-902.

Andriano TM, Tannenbaum R, Xu H, Magro CM. Linear IgA bullous dermatosis in the setting of angioimmunoblastic T-cell lymphoma. J Cutan Pathol. 2023;50(1):43-46.

Medford AJ, Oshry L, Boyraz B, Kiedrowski L, Menshikova S, Butusova A, et al. TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Ther Adv Med Oncol. 2023;15:17588359231152844.